Pharmaceutical Preparations
"Pharmaceutical Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.
| Descriptor ID |
D004364
|
| MeSH Number(s) |
D26
|
| Concept/Terms |
Pharmaceutical Preparations- Pharmaceutical Preparations
- Pharmaceutic Preparations
- Preparations, Pharmaceutic
- Preparations, Pharmaceutical
- Drugs
- Pharmaceutical Products
- Products, Pharmaceutical
|
Below are MeSH descriptors whose meaning is more general than "Pharmaceutical Preparations".
Below are MeSH descriptors whose meaning is more specific than "Pharmaceutical Preparations".
This graph shows the total number of publications written about "Pharmaceutical Preparations" by people in this website by year, and whether "Pharmaceutical Preparations" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 5 | 2 | 7 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 3 | 2 | 5 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 3 | 1 | 4 |
| 2020 | 10 | 1 | 11 |
| 2021 | 16 | 0 | 16 |
| 2022 | 1 | 5 | 6 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pharmaceutical Preparations" by people in Profiles.
-
A Comparative Study of the Tabletability of Amorphous and Crystalline Forms of Organic Drugs. Mol Pharm. 2026 Feb 02; 23(2):945-957.
-
Expert insights into the development of large-volume subcutaneous drugs with permeation enhancers: A survey examining challenges, alternatives, and future directions. Int J Pharm. 2026 Jan 20; 689:126515.
-
Machine Learning Based Quantitative Structure-Dissolution Profile Relationship. J Chem Inf Model. 2025 Jun 23; 65(12):6273-6286.
-
Special designations and the US Food and Drug Administration's "dual mandate". J Natl Cancer Inst. 2024 02 08; 116(2):177-179.
-
Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval. J Ocul Pharmacol Ther. 2023 10; 39(8):572-582.
-
Evolution of Cross-Sectional Survey Protocol Quality Over Time: A Case Series of Index U.S. REMS Knowledge Survey Protocols (2007-2020). Drug Saf. 2023 11; 46(11):1073-1087.
-
Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma. ACS Nano. 2023 12 12; 17(23):23374-23390.
-
Shape Matters: A Neglected Feature of Medication Safety : Why Regulating the Shape of Medication Containers Can Improve Medication Safety. J Med Syst. 2022 Dec 31; 47(1):6.
-
Crystal and Particle Engineering - An Indispensable Tool for Developing and Manufacturing Quality Pharmaceutical Products. Pharm Res. 2022 12; 39(12):3041-3045.
-
Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021. JAMA Netw Open. 2022 11 01; 5(11):e2242869.